Login / Signup

Auricular Vagal Neuromodulation and its Application in Patients with Heart Failure and Reduced Ejection Fraction.

Sérgio Lívio Menezes CouceiroLucas Bonacossa Sant'AnnaMariana Bonacossa Sant'AnnaRenata S Matos MenezesEvandro Tinoco MesquitaFernando Mendes Sant'Anna
Published in: Arquivos brasileiros de cardiologia (2023)
taVNS is a safe to perform and easy intervention and suggests a probable benefit in HF by improving heart rate variability, which indicates better autonomic balance. New studies with more patients are needed to answer the questions raised by this study.
Keyphrases
  • heart rate variability
  • heart rate
  • end stage renal disease
  • randomized controlled trial
  • newly diagnosed
  • ejection fraction
  • prognostic factors
  • heart failure
  • peritoneal dialysis
  • patient reported